Takeda reshaping Japan marketing effort to improve focus

Save

Asia's largest drugs firm will shift to a new structure from the start of its next fiscal year beginning 1 April, under which it will move away from a "general medical representative (MR)" system whereby each MR (sales rep) has been covering the…